Oppenheimer raises Celgene target to $168 on ‘highly positive’ study
Oppenheimer analyst Leah Rush Cann raised her price 12- to 18-month price target for shares of Celgene (CELG) to $168 from $163 citing the "highly...
Author : The Fly
Care.com slides after after unknown short seller attacks on Twitter
Shares of Care.com (CRCM), the operator of an online marketplace for finding and managing family care, are sliding after short seller "Batman Research" published a...
Bristol-Myers rises after Merck pulls cancer drug combo filing in Europe
Shares of Bristol-Myers Squibb (BMY) are on the rise after competitor Merck (MRK) announced it is withdrawing its European application for a combination regimen featuring...
Goldman sees 28% downside in GM, downgrades shares to Sell
Goldman Sachs analyst David Tamberrino downgraded General Motors (GM) to Sell from Neutral saying his price target of $32 offers 28% potential downside. The analyst...
Merck downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Geoff Meacham downgraded Merck (MRK) to Equal Weight and cut his price target for the shares to $62 from $72. The healthcare company...
On The Fly: Top five weekend stock stories
Celgene (CELG) has announced that its Ozanimod, a novel, oral, selective sphingosine 1-phosphate 1 and 5 receptor modulator, demonstrated superiority versus Biogen's (BIIB) Avonex in...
Week in review: How Trump’s policies moved stocks
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President...
On The Fly: Top stock stories at midday
The major averages opened mixed, with the Nasdaq outperforming thanks in large part to a quartet of big earnings beats from some of the biggest...
Box Office Battle: ‘Jigsaw’ likely to carve out first place weekend
Opening this weekend at 2,941 theaters is Lionsgate's (LGF.A, LGF.B) "Jigsaw," which is a return to "The Saw" franchise after seven years. The horror film...
J.C. Penney plunges after slashing 2017 earnings view
Shares of J.C. Penney (JCP) plunged in pre-market trading after the retailer slashed its forecast for fiscal 2017 as it accelerated actions to liquidate inventory...